Avalo Therapeutics, Inc.（AVTX）内部人交易：高管与董事近期交易
过去 18 个月，共有 10 位内部人为 Avalo Therapeutics, Inc.（AVTX）报告了 92 笔 Form 4 交易（最近一笔 2026-09-18）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-18 | Sullivan Christopher Ryan | Chief Financial Officer | 买入 | 12,394 | $122,453 |
| 2026-09-18 | Sullivan Christopher Ryan | Chief Financial Officer | 卖出 | 12,394 | $202,437 |
| 2026-09-11 | Sullivan Christopher Ryan | Chief Financial Officer | 买入 | 10,185 | $81,887 |
| 2026-09-11 | Sullivan Christopher Ryan | Chief Financial Officer | 卖出 | 10,185 | $179,457 |
| 2026-09-01 | Doyle Mittie | Chief Medical Officer | 买入 | 679 | $5,459 |
| 2026-09-01 | Doyle Mittie | Chief Medical Officer | 卖出 | 679 | $13,580 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | 买入 | 31,031 | $306,586 |
| 2026-08-19 | Doyle Mittie | Chief Medical Officer | 买入 | 1,000 | $12,650 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | 买入 | 2,876 | $28,415 |
| 2026-08-19 | Doyle Mittie | Chief Medical Officer | 卖出 | 1,000 | $20,000 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | 卖出 | 37,945 | $753,333 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | 卖出 | 3,749 | $74,762 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | 买入 | 37,945 | $374,897 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | 卖出 | 31,031 | $622,324 |
| 2026-08-12 | Doyle Mittie | Chief Medical Officer | 买入 | 679 | $5,459 |
| 2026-08-12 | Riley Jennifer | Chief Strategy Officer | 卖出 | 2,655 | $52,012 |
| 2026-08-12 | Doyle Mittie | Chief Medical Officer | 卖出 | 679 | $13,580 |
| 2026-07-29 | Doyle Mittie | Chief Medical Officer | 买入 | 1,000 | $12,650 |
| 2026-07-29 | Doyle Mittie | Chief Medical Officer | 卖出 | 1,000 | $20,000 |
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | 买入 | 2,875 | $36,369 |
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | 买入 | 1,779 | $14,303 |
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | 卖出 | 4,654 | $93,080 |
| 2026-06-25 | Doyle Mittie | Chief Medical Officer | 买入 | 1,450 | $11,658 |
| 2026-06-25 | Doyle Mittie | Chief Medical Officer | 卖出 | 1,450 | $26,100 |
| 2026-06-12 | Riley Jennifer | Chief Strategy Officer | 卖出 | 588 | $7,703 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18